BridgeBio Pharma, Inc. (BBIO)
68.14
-2.58
(-3.65%)
USD |
NASDAQ |
Feb 20, 16:00
68.70
+0.56
(+0.82%)
After-Hours: 20:00
BridgeBio Pharma SG&A Expense (Quarterly) : 137.62M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed, Inc. | 212.48M |
| Mirum Pharmaceuticals, Inc. | 61.91M |
| Cogent Biosciences, Inc. | 23.93M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Sarepta Therapeutics, Inc. | 91.89M |